Zymenex raised a round of funding on August 01, 2007. Investors include British Trust for the Myelin Project.

Zymenex, formerly Heme Biotech, is a a Danish biopharmaceutical company, founded in 1998, with headquarters in Hilleroed north of Copenhagen, Denmark and research laboratories in Stockholm, Sweden. Th…